MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HELLMAN, B.
Right arrow Articles by TÄLJEDAL, I.-B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HELLMAN, B.
Right arrow Articles by TÄLJEDAL, I.-B.

Molecular Pharmacology, Vol 8, 1-7, Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics

The Pancreatic beta-Cell Recognition of Insulin Secretagogues

I. Transport of Mannoheptulose and the Dynamics of Insulin Release

BO HELLMAN 1, LARS-ÅKE IDAHL 1, ÅKE LERNMARK 1, JANOVE SEHLIN 1, ERNST SIMON 1, and INGE-BERT TÄLJEDAL 1

1 Department of Histology, University of Umeå, Umeå, Sweden, and Department of Biodynamics, The Weizmann Institute of Science, Rehovot, Israel

Microdissected pancreatic islets of obese-hyperglycemic mice were used to study the uptake of mannoheptulose by beta-cells in relation to the dynamics of mannoheptulose-inhibited insulin release. Mannoheptulose uptake was faster at 37° than at 8° and was inhibited by glucose, 3-O-methylglucose, or phlorizin. The transport rate for mannoheptulose was much lower than that previously observed for glucose. Nevertheless, a few minutes of exposure to 5 mM mannoheptulose were enough to establish intracellular concentrations of the same magnitude as the concentrations inhibiting insulin release and glucose oxidation when added to the medium. This observation makes it possible to explain the prompt inhibition of insulin release noted in microperfusion experiments as due to mannoheptulose interference with the beta-cell metabolism of glucose. The mediated and glucose-sensitive transport of mannoheptulose, however, is also compatible with the idea that insulin release is governed by the binding of sugar to a receptor at the beta-cell plasma membrane.

Submitted on August 23, 1971







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics